Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Ligon

Showing results (121-130 of 324) with videos related to

Pageof 33
Sort By:
Biorxiv : the Preprint Server for Biology|April 22, 2024
A heterogeneous pharmaco-transcriptomic landscape induced by targeting a single oncogenic kinaseRoss M Giglio, Nicholas Hou, Adeya Wyatt, et al.
Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.
Neuro-Oncology|November 7, 2017
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143Antonio Omuro, Gordana Vlahovic, Michael Lim, et al.
Neuro-Oncology Advances|June 7, 2022
Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomasChristopher M Rota, Alexander T Brown, Emily Addleson, et al.
Cancer Discovery|June 5, 2014
EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencingJoshua M Francis, Cheng-Zhong Zhang, Cecile L Maire, et al.
Endocrinology|May 10, 2017
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary TumorsWenya Linda Bi, Noah F Greenwald, Shakti H Ramkissoon, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Cancers|December 18, 2019
Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in GlioblastomaJanis J Noonan, Monika Jarzabek, Frank A Lincoln, et al.
Nature Biomedical Engineering|May 20, 2025
High-throughput single-cell density measurements enable dynamic profiling of immune cell and drug response from patient samplesWeida Wu, Sarah H Ishamuddin, Thomas W Quinn, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Measuring single-cell density with high throughput enables dynamic profiling of immune cell and drug response from patient samplesWeida Wu, Sarah H Ishamuddin, Thomas W Quinn, et al.
Pageof 33

Showing results (121-130 of 324) with videos related to

Sort By:
Pageof 33
Biorxiv : the Preprint Server for Biology|April 22, 2024
A heterogeneous pharmaco-transcriptomic landscape induced by targeting a single oncogenic kinaseRoss M Giglio, Nicholas Hou, Adeya Wyatt, et al.
Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.
Neuro-Oncology|November 7, 2017
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143Antonio Omuro, Gordana Vlahovic, Michael Lim, et al.
Neuro-Oncology Advances|June 7, 2022
Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomasChristopher M Rota, Alexander T Brown, Emily Addleson, et al.
Cancer Discovery|June 5, 2014
EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencingJoshua M Francis, Cheng-Zhong Zhang, Cecile L Maire, et al.
Endocrinology|May 10, 2017
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary TumorsWenya Linda Bi, Noah F Greenwald, Shakti H Ramkissoon, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Cancers|December 18, 2019
Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in GlioblastomaJanis J Noonan, Monika Jarzabek, Frank A Lincoln, et al.
Nature Biomedical Engineering|May 20, 2025
High-throughput single-cell density measurements enable dynamic profiling of immune cell and drug response from patient samplesWeida Wu, Sarah H Ishamuddin, Thomas W Quinn, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Measuring single-cell density with high throughput enables dynamic profiling of immune cell and drug response from patient samplesWeida Wu, Sarah H Ishamuddin, Thomas W Quinn, et al.
Pageof 33